Moody's Investors Service upgrades LT- foreign currency credit rating of Catalent Pharma Solutions to "B1" from "B3"; outlook stable
2020年11月19日 CBonds
显示全文 |
该功能仅适用于授权用户
|
-
债券全称Catalent Pharma Solutions, Inc.
-
注册地国家USA
-
行业Pharmaceutical Preparation and Biotechnology
股票